Back to search

United States· US:0093-5002_a035edd9-948f-4168-b74b-9961a2cb219a

Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide

A medicinal product containing olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide, registered in United States by Teva Pharmaceuticals USA, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOlmesartan Medoxomil, Amlodipine and …ATC—REGISTER NO.US:0093-5002_a035edd9…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0093500256
    30 TABLET, FILM COATED in 1 BOTTLE (0093-5002-56)
  • ndc11
    0093-5002-56

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Amelior Plus Hct
  • Belgium · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
  • Bulgaria · Олмезид Трио, Олместа А Плюс
  • Cyprus · Olmedipin Plus, Orizal Plus
  • Czechia · Sintonyn Combi
  • Germany · Olmeamlo Hct, Olmeamlodipinhct Puren
  • Estonia · Gaduar, Olmesartan Medoxomil/Amlodipine/Hct Accord
  • Spain · Albis Plus, Balzak Plus
  • United Kingdom (Northern Ireland) · Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm, Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Milpharm Limited
  • Greece · Comprelan Plus, Gaduar
  • Croatia · Omelia
  • Hungary · Duactan Hct
  • Ireland · Konverge Plus, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
  • Italy · Gaduar, Olmesartan, Amlodipina E Idroclorotiazide Eg
  • Lithuania · Gaduar, Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord
  • Luxembourg · Forzaten/Hct, Olmesartan/Amlodipin/Hct Viatris
  • Latvia · Gaduar, Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide Accord
  • Malta · Konverge Plus
  • Netherlands · Belfor Hct, Capenon Hct
  • Poland · Amolisa Hct, Elestar Hct
  • Portugal · Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Alter, Amlodipina + Olmesartan Medoxomilo + Hidroclorotiazida Generis
  • Romania · Inovum Hct, Sevikar Hct
  • Slovenia · Olectan Hct, Olsitri
  • Slovakia · Folgan Hct

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d142a8c0-5388-45ff-97f7-98dd7fb9dee1
GET /v1/drugs/d142a8c0-5388-45ff-97f7-98dd7fb9dee1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "40; 10; 25",
  "substance": "OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE",
  "productndc": "0093-5002",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1; mg/1",
  "application_number": "ANDA202491",
  "marketing_category": "ANDA"
}

See everything about olmesartan medoxomil; amlodipine besylate; hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.